Pharmena S.A. (PHR) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.078x

Based on the latest financial reports, Pharmena S.A. (PHR) has a cash flow conversion efficiency ratio of -0.078x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-820.00K ≈ $-225.68K USD) by net assets (zł10.54 Million ≈ $2.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pharmena S.A. net asset quality index to measure how much of total assets are equity-financed.

Pharmena S.A. - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Pharmena S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Pharmena S.A. to evaluate the quality of earnings relative to operating cash generation.

Pharmena S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmena S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Leslies Inc NASDAQ:LESL	0.166x
Orex Minerals Inc V:REX	-0.271x
hGears AG XETRA:HGEA	-0.050x
Redivium Ltd AU:RIL	2.594x
Bawat Water Technologies AB ST:BAWAT	0.190x
Digjam Limited NSE:DIGJAMLMTD	-0.719x
LABORATORIO FARMAC.ERFO F:RK7	N/A
Kohinoor Foods Limited NSE:KOHINOOR	-1.314x

Annual Cash Flow Conversion Efficiency for Pharmena S.A. (2008–2024)

The table below shows the annual cash flow conversion efficiency of Pharmena S.A. from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Pharmena S.A. worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł12.42 Million ≈ $3.42 Million	zł-2.53 Million ≈ $-696.57K	-0.204x	-113.71%
2023-12-31	zł22.23 Million ≈ $6.12 Million	zł33.03 Million ≈ $9.09 Million	1.486x	+654.93%
2022-12-31	zł-6.79 Million ≈ $-1.87 Million	zł1.82 Million ≈ $500.62K	-0.268x	-142.53%
2021-12-31	zł-5.12 Million ≈ $-1.41 Million	zł-3.23 Million ≈ $-887.57K	0.630x	-90.23%
2020-12-31	zł-348.00K ≈ $-95.77K	zł-2.24 Million ≈ $-617.31K	6.445x	+344.95%
2019-12-31	zł5.00 Million ≈ $1.37 Million	zł-13.15 Million ≈ $-3.62 Million	-2.631x	-241.00%
2018-12-31	zł1.94 Million ≈ $532.82K	zł3.61 Million ≈ $994.35K	1.866x	+973.60%
2017-12-31	zł3.56 Million ≈ $980.04K	zł619.00K ≈ $170.36K	0.174x	+208.74%
2016-12-31	zł5.94 Million ≈ $1.64 Million	zł-950.00K ≈ $-261.45K	-0.160x	+66.80%
2015-12-31	zł8.67 Million ≈ $2.39 Million	zł-4.17 Million ≈ $-1.15 Million	-0.481x	-9.53%
2014-12-31	zł13.08 Million ≈ $3.60 Million	zł-5.75 Million ≈ $-1.58 Million	-0.440x	-106.82%
2013-12-31	zł18.05 Million ≈ $4.97 Million	zł-3.84 Million ≈ $-1.06 Million	-0.213x	+52.93%
2012-12-31	zł8.98 Million ≈ $2.47 Million	zł-4.05 Million ≈ $-1.12 Million	-0.451x	-1213.85%
2011-12-31	zł16.45 Million ≈ $4.53 Million	zł666.91K ≈ $183.54K	0.041x	+159.65%
2010-12-31	zł15.91 Million ≈ $4.38 Million	zł-1.08 Million ≈ $-297.50K	-0.068x	-512.69%
2009-12-31	zł16.16 Million ≈ $4.45 Million	zł-179.22K ≈ $-49.32K	-0.011x	-437.74%
2008-12-31	zł15.78 Million ≈ $4.34 Million	zł-32.56K ≈ $-8.96K	-0.002x	--

About Pharmena S.A.

WAR:PHR Poland Biotechnology

Market Cap

$9.59 Million

zł34.86 Million PLN

Market Cap Rank

#27166 Global

#290 in Poland

Share Price

zł3.13

Change (1 day)

-0.63%

52-Week Range

zł2.55 - zł4.22

All Time High

zł28.01